Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06293352
Other study ID # STU00220012
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 2024
Est. completion date December 2026

Study information

Verified date February 2024
Source Northwestern University
Contact Melissa J Shauver, MPH
Phone 312-472-6024
Email melissa.shauver@northwestern.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the US, if you get an infection in your artificial knee joint that doesn't heal with antibiotics alone, the standard treatment is a two-stage revision of the artificial knee. In the first stage, your surgeon will remove your artificial knee and clean out the area around the knee. They will then place an antibiotic spacer. An antibiotic spacer is a type of artificial joint that will release antibiotics in to the knee space continuously over time. The spacer allows only very basic function of the knee. You may need to use crutches or a walker while the antibiotic spacer is in place. After surgery to place the antibiotic spacer, your surgeon may prescribe a course of antibiotics as well. Because the antibiotic spacer is not as durable as a regular artificial joint, after the infection is gone, another surgery is required to take the spacer out and put a new artificial knee joint in. There is another way for artificial joint infections to be treated. This is a one-stage revision. In this treatment, the surgeon will remove your artificial knee and clean out the area around the knee. Then they will place a new artificial knee in using a special kind of cement that contains antibiotics. The cement will release antibiotics in to the knee space continuously over time (your surgeon may prescribe a course of antibiotics as well). The new artificial joint with antibiotic cement will function almost the same as your original artificial knee. This means that while the infection is healing you will be able to do most of your regular daily activities. However, the antibiotic cement is not as durable as what is normally used to implant an artificial knee. The artificial knee with the antibiotic cement may need to be replaced with a regular artificial knee. When replacement will need to be done is dependent on your weight, bone strength and activity level, among other things. When it is time to replace the antibiotic cement artificial knee, you will have another surgery where the surgeon will take the antibiotic cement artificial knee and but a new artificial knee joint in. We know that both the one- and two-stage revision work equally well to heal the infection, but we don't know which patients prefer or which provides better function after many years. This study will randomly assign patients to receive either a one-stage or two-stage revision and then follow them for 5 years to ask them about pain, function, and satisfaction.


Description:

This study compares to currently used treatments for chronic peri-prosthetic joint infections: Treatment with an all-cement articulating spacer and treatment with a durable, real-component articulating spacer. An all-cement articulating spacer will be defined as follows: An articulating spacer with a tibial and femoral component made of cement using molds, that are cemented in place; use of high-dose antibiotic cement (at least 2g/batch, including vancomycin and tobramycin); use of dowels at discretion of surgeon; 6 weeks IV antibiotics; intent to reimplant definitive prosthesis if infection eradicated. A durable, real-component articulating spacer will be defined as follows: Uses metal (or ceramicized metal) on plastic for bearing surface; use of high-dose antibiotic cement (at least 2g/batch, including vancomycin and tobramycin); no cones/sleeves, no pressurized cement in canal; use of stems/dowels/augments and level of constraint at discretion of surgeon; 6 weeks IV antibiotics; intent to leave in situ indefinitely/until clinical failure. This will be a study with 2 cohorts. We will have a randomized cohort, as well as a nonrandomized prospective observational cohort. Surgery will be performed by current treatment guidelines in the same manner as if the patient was not in a research study. All questionnaires will be administered via iPad/online. The questionnaires administered at the preoperative appointment will consist preoperative patient-reported outcomes (PROs). The preoperative PROs will be determined utilizing PROMIS questionnaires including PROMI-10 Survey and the Knee Injury and Osteoarthritis Outcome Score (KOOS-12), In addition, patient demographic characteristics will be collected including age, sex, race, education and insurance status as well as self-reported comorbidity data. The questionnaires will be administered again at the 6-week and 6-month, 12-month, and 24- month postoperative time points. In addition, the PROMIS depression scale will be collected at 6 weeks. The presence and absence any complications, along with complication severity as determined by the PI, during the procedure or during recovery will be extracted from the EMR by the PI and/or Co-investigator after surgery and after every postoperative visit through the 24-month visit.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 153
Est. completion date December 2026
Est. primary completion date March 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients diagnosed with a chronic periprosthetic joint infection after a primary total knee arthroplasty with plan for explant and placement of an antibiotic spacer - PJI defined according to Musculoskeletal Infection Society (MSIS) 2018 Consensus Criteria Exclusion Criteria: - Patients who are unable to consent - Infection at site of revision TKA - Soft tissue envelope compromise - Allergies to study materials (cement, vancomycin, tobramycin) - Incompetent extensor mechanism - Extensive bone loss Randomization-specific exclusion criteria - Extensive soft tissue defect - Extensor mechanism compromise

Study Design


Intervention

Device:
All-cement articulating spacer
Two-stage intervention
Durable, real-component articulating spacer
Single stage intervention
Rigid Spacer
Observation intervention

Locations

Country Name City State
United States Northwestern Medicine Chicago Illinois

Sponsors (1)

Lead Sponsor Collaborator
Northwestern University

Country where clinical trial is conducted

United States, 

References & Publications (1)

Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, Chen AF, Shohat N. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018 May;33(5):1309-1314.e2. doi: 10.1016/j.arth.2018.02.078. Epub 2018 Feb 26. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Revision/reoperation for infection (defined by positive culture by MSIS criteria) Count and percentage of occurrence of revision/reoperation for infection 24 months after surgery
Other revision for aseptic failure (defined by negative culture by MSIS criteria) Count and percentage of occurrence of reoperation for aseptic failure 24 months after surgery
Primary 24 month Knee Injury and Osteoarthritis Outcome Score (KOOS) Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. 24 months after surgery
Secondary 6 week Knee Injury and Osteoarthritis Outcome Score (KOOS) Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. 6 weeks after surgery
Secondary 6 week 10-item PROMIS Global Health survey (PROMIS-10) Raw PROMIS-10 (v1.0) scores for Physical Health (PH) and Mental Health (MH) will be converted to standardized T-score values. A T-score of 50 represents the mean of the general population and higher scores indicate better physical or mental health. 6 weeks after surgery
Secondary 6 month Knee Injury and Osteoarthritis Outcome Score (KOOS) Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. 6 months after surgery
Secondary 6 month 10-item PROMIS Global Health survey (PROMIS-10) Raw PROMIS-10 (v1.0) scores for Physical Health (PH) and Mental Health (MH) will be converted to standardized T-score values. A T-score of 50 represents the mean of the general population and higher scores indicate better physical or mental health. 6 months after surgery
Secondary 12 month Knee Injury and Osteoarthritis Outcome Score (KOOS) Scores range from 0 to 100 with a score of 0 indicating the worst possible knee symptoms and 100 indicating no knee symptoms. 12 months after surgery
Secondary 12 month 10-item PROMIS Global Health survey (PROMIS-10) Raw PROMIS-10 (v1.0) scores for Physical Health (PH) and Mental Health (MH) will be converted to standardized T-score values. A T-score of 50 represents the mean of the general population and higher scores indicate better physical or mental health. 12 months after surgery
Secondary 24 month 10-item PROMIS Global Health survey (PROMIS-10) Raw PROMIS-10 (v1.0) scores for Physical Health (PH) and Mental Health (MH) will be converted to standardized T-score values. A T-score of 50 represents the mean of the general population and higher scores indicate better physical or mental health. 24 months after surgery
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Recruiting NCT05002387 - Diagnostic Knee Needle Arthroscopy in Predicting Unicompartmental Knee Osteoarthritis N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03008967 - A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark N/A
Withdrawn NCT02255877 - ZIPS Study - Zip Incision Approximation vs. STAPLE Phase 4
Completed NCT02642731 - Kidney Biomarkers of Acute Kidney Injury in Patients With Knee Arthroplasty N/A
Completed NCT01799772 - The Feasibility of a Comprehensive Behavioral Intervention in Patient Post TKA Phase 1/Phase 2
Completed NCT02525588 - Polyethylene Wear Study on the Triathlon Total Knee Prosthesis N/A
Completed NCT02520531 - Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty N/A
Completed NCT03183856 - Comparison of Ambulatory and Functional Improvement by Morning Walk N/A
Completed NCT03569397 - Music Therapy Versus Control for Total Knee Arthroplasty N/A
Terminated NCT02711592 - Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study N/A
Completed NCT03145493 - Effect of Suction Drains in Total Knee Arthroplasty With Tranexamic Acid N/A
Terminated NCT05602701 - Preoperative Prediction of Postoperative Physical Function
Recruiting NCT03570944 - Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Withdrawn NCT02553122 - The Combined Efficacy of Evicel and Tranexamic Acid on Total Knee Arthroplasty Phase 3
Completed NCT02773537 - Motor-Sparing Peripheral Nerve Blockade Facilitates Mobility Post Total Knee Arthroplasty: A Randomized Controlled Trial N/A
Recruiting NCT02385383 - An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study N/A
Completed NCT02121392 - Epidural Catheter With or Without Adductor Canal Nerve Block for Postoperative Analgesia Following Total Knee Arthroplasty N/A
Terminated NCT02155712 - Triathlon Tritanium Knee Outcomes Study N/A